166 related articles for article (PubMed ID: 24008393)
1. The age factor in survival of a population cohort of well-differentiated thyroid cancer.
Mazurat A; Torroni A; Hendrickson-Rebizant J; Benning H; Nason RW; Pathak KA
Endocr Connect; 2013; 2(3):154-60. PubMed ID: 24008393
[TBL] [Abstract][Full Text] [Related]
2. Stage II differentiated thyroid cancer: A mixed bag.
Pathak KA; Klonisch TC; Nason RW
J Surg Oncol; 2016 Jan; 113(1):94-7. PubMed ID: 26628095
[TBL] [Abstract][Full Text] [Related]
3. Identifying the most appropriate age threshold for TNM stage grouping of well-differentiated thyroid cancer.
Hendrickson-Rebizant J; Sigvaldason H; Nason RW; Pathak KA
Eur J Surg Oncol; 2015 Aug; 41(8):1028-32. PubMed ID: 25986855
[TBL] [Abstract][Full Text] [Related]
4. Patient and tumor factors contributing to distant metastasis in well-differentiated thyroid cancer: a retrospective cohort study.
Khan U; Al Afif A; Aldaihani A; MacKay C; Rigby MH; Rajaraman M; Imran SA; Bullock MJ; Taylor SM; Trites JRB; Hart RD
J Otolaryngol Head Neck Surg; 2020 Nov; 49(1):78. PubMed ID: 33198797
[TBL] [Abstract][Full Text] [Related]
5. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the prognostic value and N1b changes of the eighth TNM/AJCC staging system for differentiated thyroid carcinoma.
Zhi J; Wu Y; Hu L; Zhao J; Liu H; Ruan X; Hou X; Zhang J; Zheng X; Gao M
Int J Clin Oncol; 2020 Jan; 25(1):59-66. PubMed ID: 31414270
[TBL] [Abstract][Full Text] [Related]
7. Patient Age Is an Independent Risk Factor of Relapse of Differentiated Thyroid Carcinoma and Improves the Performance of the American Thyroid Association Stratification System.
Trimboli P; Piccardo A; Signore A; Valabrega S; Barnabei A; Santolamazza G; Di Paolo A; Stati V; Chiefari A; Vottari S; Simmaco M; Ferrarazzo G; Ceriani L; Appetecchia M; Giovanella L
Thyroid; 2020 May; 30(5):713-719. PubMed ID: 31973653
[No Abstract] [Full Text] [Related]
8. LATERAL NECK DISSECTION FOR AGGRESSIVE VARIANTS OF WELL-DIFFERENTIATED THYROID CANCER.
Lombardi D; Taboni S; Paderno A; Giordano D; Bertagna F; Albano D; Barbieri V; Spriano G; Mercante G; Piana S; Bellafiore S; Cappelli C; Nicolai P
Endocr Pract; 2019 Apr; 25(4):328-334. PubMed ID: 30995431
[No Abstract] [Full Text] [Related]
9. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions.
Tam S; Boonsripitayanon M; Amit M; Fellman BM; Li Y; Busaidy NL; Cabanillas ME; Dadu R; Sherman S; Waguespack SG; Williams MD; Goepfert RP; Gross ND; Perrier ND; Sturgis EM; Zafereo ME
Thyroid; 2018 Oct; 28(10):1301-1310. PubMed ID: 30141373
[TBL] [Abstract][Full Text] [Related]
10. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
11. Prognostic nomograms to predict oncological outcome of thyroid cancers.
Pathak KA; Mazurat A; Lambert P; Klonisch T; Nason RW
J Clin Endocrinol Metab; 2013 Dec; 98(12):4768-75. PubMed ID: 24152685
[TBL] [Abstract][Full Text] [Related]
12. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
[No Abstract] [Full Text] [Related]
14. Age greater than 60 years portends a worse prognosis in patients with papillary thyroid cancer: should there be three age categories for staging?
Kauffmann RM; Hamner JB; Ituarte PHG; Yim JH
BMC Cancer; 2018 Mar; 18(1):316. PubMed ID: 29566662
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and long-term outcomes for parapharyngeal metastases of well-differentiated thyroid cancer during
Deng XZ; Shi YF; Shen CT; Song HJ; Wang J; Fan YB; Luo QY; Qiu ZL
Clin Endocrinol (Oxf); 2023 Jul; 99(1):92-102. PubMed ID: 37029081
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
17. TUMOR SIZE IS AN INDEPENDENT PREDICTOR OF MORTALITY RISK IN DIFFERENTIATED THYROID CANCER PATIENTS WITH T4 DISEASE.
Wang Z; Zhang Q; Ye H; Jia C; Lv Z; Liu J; Yin Z
Endocr Pract; 2020 May; 26(5):499-507. PubMed ID: 31968190
[No Abstract] [Full Text] [Related]
18. Surgical treatment of papillary and follicular thyroid carcinoma.
Lin JD; Jeng LB; Chao TC; Weng HF; Huang HS
Int Surg; 1996; 81(1):61-6. PubMed ID: 8803709
[TBL] [Abstract][Full Text] [Related]
19. A critical analysis of the current TNM classification for differentiated thyroid carcinoma in young patients: Time for a change?
Wang W; Bai N; Li X
Front Endocrinol (Lausanne); 2022; 13():939131. PubMed ID: 36339438
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of extranodal extension in papillary thyroid carcinomas: A propensity score matching analysis and proposal for incorporation into current tumor, lymph node, metastasis staging.
Genpeng L; Pan Z; Tao W; Rixiang G; Jingqiang Z; Zhihui L; Jianyong L
Surgery; 2022 Feb; 171(2):368-376. PubMed ID: 34482990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
